Odonate Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Net Income	7.33	42.94	-68.32	-126.35	-108.72	Upgrade
Depreciation & Amortization	0.02	0.34	1.05	0.45	0.38	Upgrade
Share-Based Compensation	0	0	0	9.83	11.44	Upgrade
Other Operating Activities	1.39	-41.49	-8.46	2.95	0.26	Upgrade
Operating Cash Flow	8.74	1.8	-75.73	-113.13	-96.64	Upgrade
Operating Cash Flow Growth	386.91%	-	-	-	-	Upgrade
Capital Expenditures	0	0	-0.03	-0.43	-0.17	Upgrade
Acquisitions	0	0.05	0	0	0	Upgrade
Change in Investments	-54.65	-58.4	-	-	-	Upgrade
Other Investing Activities	74.8	-	-	-	-	Upgrade
Investing Cash Flow	20.15	-58.35	-0.03	-0.43	-0.17	Upgrade
Common Stock Issued	0	0	0.83	87.38	135.1	Upgrade
Share Repurchases	0	-1.62	-13.58	0	0	Upgrade
Other Financing Activities	-0.2	-3.24	-27.15	2.98	3.58	Upgrade
Financing Cash Flow	-0.2	-1.62	-12.75	90.37	138.68	Upgrade
Net Cash Flow	28.82	-58.17	-88.37	-23.2	41.87	Upgrade
Free Cash Flow	8.74	1.8	-75.75	-113.56	-96.8	Upgrade
Free Cash Flow Growth	386.91%	-	-	-	-	Upgrade
Free Cash Flow Per Share	3.05	616.30	-998.76	-1727.84	-1599.11	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.